SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kevin Podsiadlik who wrote (3912)8/7/2001 4:21:34 PM
From: rli123  Read Replies (1) of 5582
 
Kevin ---

What you're missing is an understanding of the Asset Purchase Agreement --- which, according to the Proxy filed with the SEC, includes:

"As additional consideration, Wrigley will pay royalties to the Company
equal to 5% of:

* gross manufacturing sales, if any, of certain products (the "P&G
Products") developed pursuant to the Joint Development Agreement
between the Company and The Procter & Gamble Company for a period of
three years after the first date on which any P&G Product is launched,
subject to a maximum of $1.2 million; and

My assumption is that the Crest dental gum qualifies (I think this is a reasonable assumption, although certainly some may differ). So, the answer to my question, Dan, is 5% up to $1.2 million. Not alot, but we'll take it. And Hank --- that's 5% of GROSS MANUFACTURING SALES, not profits --- are you still hallucinating?

rli
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext